Delivery Order SPE2DB20D1004-SPE2DB22FE8E9

Award Date 11/2/21
Potential Completion Date 11/3/21
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Pantoprazole Sodium Delayed Release 40 mg tablets in 1,000 count bottles. The contract, valued at $1,365.61, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 10, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,872.98, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of 1,000 tablets of Pantoprazole Sodium Delayed-Release 40 mg, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award ceiling value is $1,657.53 and the contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM). The award is not designated...
This federal contract award is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets to the Defense Logistics Agency (DLA). The $1,722.29 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive...
This federal contract award is for the delivery of 450 tablets of Pantoprazole Sodium Delayed-Release 40 mg, a prescription medication. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables efficient...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,247.30, is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count containers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg Tablets, in a quantity of 1,000 tablets, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,473.51 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,146.52 Firm Fixed Price Delivery Order contract is for the supply of 4,567,364,223 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has a period of performance through February 25, 2025 and was awarded on February 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,732,472 units of pantoprazole sodium delayed-release 40 mg tablets, with a ceiling value of $1,670.76. The contract is a firm-fixed price delivery order with a period of performance through March 31, 2025. This award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets. The contract has a ceiling value of $1,680.79 and is a Firm Fixed Price Delivery Order, with a period of performance through June 3, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FE8E9
    Delivery Order

This federal contract award is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $1,075.17 and a completion date of November 3, 2021. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:47 AM